Cabaron, Rick Jhon C.

HRN: 24-53-04  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/31/2024
02/06/2024
IVT
250mg
Q6
Pneumonia
Waiting Final Action 

Indication:  Empiric    Type of Infection:  URTIIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: